Mutual of America Capital Management LLC decreased its position in The Bancorp, Inc. (NASDAQ:TBBK – Free Report) by 13.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 7,364 shares of the bank’s stock after selling 1,145 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Bancorp were worth $394,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Blue Trust Inc. raised its position in shares of Bancorp by 72.3% during the 3rd quarter. Blue Trust Inc. now owns 627 shares of the bank’s stock valued at $34,000 after buying an additional 263 shares in the last quarter. GAMMA Investing LLC boosted its holdings in shares of Bancorp by 60.5% in the 2nd quarter. GAMMA Investing LLC now owns 772 shares of the bank’s stock worth $29,000 after purchasing an additional 291 shares during the period. US Bancorp DE bought a new position in shares of Bancorp during the 3rd quarter valued at approximately $83,000. EverSource Wealth Advisors LLC raised its holdings in Bancorp by 345.7% during the 1st quarter. EverSource Wealth Advisors LLC now owns 1,640 shares of the bank’s stock valued at $55,000 after buying an additional 1,272 shares during the period. Finally, Summit Asset Management LLC bought a new stake in Bancorp in the third quarter worth $281,000. 96.22% of the stock is currently owned by institutional investors.
Bancorp Trading Up 0.4 %
TBBK opened at $59.05 on Thursday. The stock’s 50 day moving average price is $54.00 and its 200-day moving average price is $46.37. The stock has a market cap of $2.83 billion, a price-to-earnings ratio of 15.01 and a beta of 1.46. The company has a debt-to-equity ratio of 0.18, a quick ratio of 0.85 and a current ratio of 0.88. The Bancorp, Inc. has a one year low of $29.92 and a one year high of $61.17.
Wall Street Analyst Weigh In
Separately, StockNews.com upgraded shares of Bancorp from a “sell” rating to a “hold” rating in a research report on Monday.
Get Our Latest Stock Analysis on TBBK
Insiders Place Their Bets
In other Bancorp news, CMO Maria Wainwright sold 11,357 shares of the firm’s stock in a transaction dated Tuesday, October 29th. The stock was sold at an average price of $50.08, for a total value of $568,758.56. Following the completion of the sale, the chief marketing officer now owns 23,291 shares of the company’s stock, valued at approximately $1,166,413.28. This trade represents a 32.78 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Thomas G. Pareigat sold 5,466 shares of the company’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $49.03, for a total transaction of $267,997.98. Following the transaction, the executive vice president now owns 73,114 shares in the company, valued at $3,584,779.42. The trade was a 6.96 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 26,983 shares of company stock worth $1,345,366 in the last three months. Corporate insiders own 5.20% of the company’s stock.
Bancorp Profile
The Bancorp, Inc operates as the bank holding company for The Bancorp Bank, National Association that provides banking products and services in the United States. It offers a range of deposit products and services, including checking, savings, time, money market, and commercial accounts; overdrafts; and certificates of deposit.
Featured Stories
- Five stocks we like better than Bancorp
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How to Start Investing in Real Estate
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- The 3 Best Blue-Chip Stocks to Buy Now
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Bancorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bancorp and related companies with MarketBeat.com's FREE daily email newsletter.